Ruirui Zhao

Fujian Provincial Key Laboratory Of Cancer Metastasis Chemoprevention And Chemotherapy
Fuzhou, 350108, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma.

Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma.

Journal: Asian journal of pharmaceutical sciences

Published: December 07, 2022

Carrier-free nanodrugs for in vivo NIR bioimaging and chemo-photothermal synergistic therapy.

Carrier-free nanodrugs for in vivo NIR bioimaging and chemo-photothermal synergistic therapy.

Journal: Journal of materials chemistry. B

Published: September 05, 2019

Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid.

Evolution from small molecule to nano-drug delivery systems: An emerging approach for cancer therapy of ursolic acid.

Journal: Asian journal of pharmaceutical sciences

Published: May 19, 2019

Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma.

Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma.

Journal: European journal of medicinal chemistry

Published: April 06, 2019

Small Molecule Nanodrug Assembled of Dual-Anticancer Drug Conjugate for Synergetic Cancer Metastasis Therapy.

Small Molecule Nanodrug Assembled of Dual-Anticancer Drug Conjugate for Synergetic Cancer Metastasis Therapy.

Journal: Bioconjugate chemistry

Published: September 26, 2018

Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy.

Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy.

Journal: Molecular pharmaceutics

Published: May 05, 2018

Corrigendum to "Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy" [Eur. J. Pharm. Sci. 111 (1 January 2018) 492-502].

Corrigendum to "Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy" [Eur. J. Pharm. Sci. 111 (1 January 2018) 492-502].

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: February 04, 2018

A carrier-free dual-drug nanodelivery system functionalized with aptamer specific targeting HER2-overexpressing cancer cells.

A carrier-free dual-drug nanodelivery system functionalized with aptamer specific targeting HER2-overexpressing cancer cells.

Journal: Journal of materials chemistry. B

Published: December 14, 2017

Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies.

Ursolic Acid in Cancer Treatment and Metastatic Chemoprevention: From Synthesized Derivatives to Nanoformulations in Preclinical Studies.

Journal: Current cancer drug targets

Published: December 11, 2017

Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.

Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.

Journal: Acta biomaterialia

Published: October 24, 2017

Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy.

Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: August 27, 2017

Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.

Dual-Targeting Multifuntional Mesoporous Silica Nanocarrier for Codelivery of siRNA and Ursolic Acid to Folate Receptor Overexpressing Cancer Cells.

Journal: Journal of agricultural and food chemistry

Published: August 04, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026